Construction method and application of embryonic development retardation animal model
By constructing an embryonic developmental delay model using fetal bovine serum or FABP4 expression inhibitors and applying DIA proteomics technology, the problems of model instability and analytical difficulties in existing technologies have been solved, achieving model stability and comprehensive analysis of molecular mechanisms, and providing an effective tool for research and drug screening.
Patent Information
- Application Number
- CN202610287208.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-10
- Publication Date
- 2026-05-15
AI Technical Summary
Existing technologies make it difficult to stably construct models of embryonic developmental delay, and traditional proteomics methods cannot fully elucidate its molecular mechanisms, leading to research difficulties.
An animal model of embryonic developmental delay was constructed using fetal bovine serum or fatty acid-binding protein 4 expression inhibitors. Combined with data-independent acquisition (DIA) proteomics technology, low-abundance proteins were accurately quantified, and changes in protein expression profiles were comprehensively analyzed.
A stable and reliable model of embryonic developmental delay was constructed, with a clear phenotype. This model can comprehensively analyze the multidimensional regulatory mechanisms of embryonic developmental delay, providing an ideal experimental model for research and can be used to screen candidate drugs for the prevention or treatment of embryonic developmental delay.